Wuxi Hyatech Co

Wuxi Hyatech Co Forward P/E

The Forward P/E Ratio of Wuxi Hyatech Co (688510.SS) as of Oct 22, 2026 is 112.52. In the previous year, Forward P/E Ratio was 90.82 — a change of 23.89% (higher).

Forward P/E

112.52

YoY

23.89%

Last updated:

Forward P/E Ratio of Wuxi Hyatech Co is 2025 112.52 . Forward P/E Ratio of Wuxi Hyatech Co was 2024 90.82 . It decreases by 23.89% higher compared to the previous year.

The Wuxi Hyatech Co Forward P/E history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Forward P/E
Date
Forward P/E
Jan 1, 2018
821.60 CNY
Jan 1, 2019
272.41 CNY
Jan 1, 2020
191.86 CNY
Jan 1, 2021
473.47 CNY
Jan 1, 2022
572.80 CNY
Jan 1, 2023
127.40 CNY
Jan 1, 2024
90.82 CNY
Jan 1, 2025
112.52 CNY
The Wuxi Hyatech Co Forward P/E history
YEARForward P/EYoY
112.52+23.89%
90.82-28.71%
127.40-77.76%
572.80+20.98%
473.47+146.78%
191.86-29.57%
272.41-66.84%
821.60-152.34%
-1,569.78+141.43%
-650.19+4.42%
-622.64-16.61%
-746.68—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Wuxi Hyatech Co Stock analysis

What does Wuxi Hyatech Co do? Wuxi Hyatech Co Ltd generates revenue through the research and development, manufacturing, and sales of key components for aero-engines and medical orthopedic implant forgings. The company produces high-performance components including aviation turbofan engine compressor blades, rotating parts, and structural parts, which are sold domestically and internationally. Its primary customers are aerospace manufacturers and medical device companies requiring specialized forgings for engine parts and orthopedic implants. The firm targets the aerospace and medical sectors with its focus on precision-engineered components for critical applications. The company's product portfolio includes aviation turbofan engine compressor blades, rotating parts, and structural parts, alongside medical orthopedic implant forgings. These products are distributed across domestic and overseas markets, serving both the Chinese aerospace industry and international medical device markets. Wuxi Hyatech's revenue streams are derived from direct sales of these specialized components to industrial and medical clients without third-party intermediaries. Wuxi Hyatech's business model centers on supplying high-precision components for aero-engines and medical orthopedic implants. The company's manufacturing capabilities enable it to produce critical parts for aircraft engines and orthopedic devices, with a focus on domestic and international industrial clients. Revenue is generated through the sale of these specialized forgings to aerospace and medical sectors, leveraging its R&D expertise in component production. Wuxi Hyatech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Wuxi Hyatech Co stock

Forward P/E Ratio of Wuxi Hyatech Co is 112.52 in 2025.

Forward P/E Ratio of Wuxi Hyatech Co changed from 90.82 to 112.52, representing a 23.89% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Wuxi Hyatech Co since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Wuxi Hyatech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Wuxi Hyatech Co

All Key Metrics — Wuxi Hyatech Co